Cargando…

Engagement with the HCV care cascade among high-risk groups: A population-based study

HCV elimination requires a thorough understanding of the care cascade. A direct-acting antiviral (DAA)-era description of the care cascade has not been undertaken in Ontario, Canada’s most populous jurisdiction. Our primary objective was to describe the current population-level care cascade in the g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Erman, Aysegul, Everett, Karl, Wong, William W.L., Forouzannia, Farinaz, Greenaway, Christina, Janjua, Naveed, Kwong, Jeffrey C., Sander, Beate
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412431/ https://www.ncbi.nlm.nih.gov/pubmed/37556245 http://dx.doi.org/10.1097/HC9.0000000000000222

Ejemplares similares

Impact of COVID‐19 pandemic on HCV care cascade in Rwanda: Ecological study from July 2019 to June 2021
por: Makuza, Jean Damascene, et al.
Publicado: (2022)

Insights on the Russian HCV care cascade: minimal HCV treatment for HIV/HCV co-infected PWID in St. Petersburg
por: Tsui, Judith I., et al.
Publicado: (2016)

Experiences of an HCV Patient engagement group: a seven-year journey
por: Kixmiller, Scott, et al.
Publicado: (2021)

Characterizing the cascade of care for hepatitis C virus infection among Status First Nations peoples in Ontario: a retrospective cohort study
por: Mendlowitz, Andrew B., et al.
Publicado: (2023)

The impact of COVID-19 on the cascade of care of HCV in the US and China
por: Yeo, Yee Hui, et al.
Publicado: (2022)

The impact of COVID-19 pandemic control measures on HCV treatment initiation in British Columbia, Canada
por: Janjua, Naveed, et al.
Publicado: (2022)

1483. Real-time Creation of HCV Treatment Cascades in Clinics to Improve HCV Treatment Rates Among Patients with HIV/HCV Co-infection
por: Wegener, Maximilian D, et al.
Publicado: (2023)

Syndemic Characterization of HCV, HBV, and HIV Co-infections in a Large Population Based Cohort Study
por: McKee, Geoffrey, et al.
Publicado: (2018)

Trent HCV study: mortality rates and ethnic differences in outcome
por: Irving, W.L.
Publicado: (2006)

A Systematic Review of the Cost-Effectiveness of Cleft Care in Low- and Middle-Income Countries: What is Needed?
por: Chung, Karen Y., et al.
Publicado: (2022)

932. Creating a Statewide HCV Treatment Cascade for HIV/HCV Co-Infected Persons Using a Partnership with DPH
por: Wegener, Maximilian D, et al.
Publicado: (2020)

Estimation of fibrosis progression rates for chronic hepatitis C: a systematic review and meta-analysis update
por: Erman, Aysegul, et al.
Publicado: (2019)

Health care costs associated with chronic hepatitis C virus infection in Ontario, Canada: a retrospective cohort study
por: Wong, William W.L., et al.
Publicado: (2021)

The Population Level Cascade of Care for Hepatitis C in British Columbia, Canada: The BC Hepatitis Testers Cohort (BC-HTC)
por: Janjua, Naveed Z., et al.
Publicado: (2016)

The HCV Revolution Did Not Happen Overnight
por: Kwong, Ann D.
Publicado: (2014)

Psychiatrist-led treatment of hepatitis C (HCV) at an opioid agonist treatment (OAT) clinic in Stockholm - enhancing the HCV treatment care cascade
por: Kåberg, M., et al.
Publicado: (2022)

Drug Authorization for Sofosbuvir/Ledipasvir (Harvoni) for Chronic HCV Infection in a Real-World Cohort: A New Barrier in the HCV Care Cascade
por: Do, Albert, et al.
Publicado: (2015)

933. Cured vs. Not Yet Treated: Population Differences for HIV/HCV Co-infected Patients Navigating the HCV Care Cascade in 11 Connecticut Clinics
por: Brooks, Ralph P, et al.
Publicado: (2020)

Hepatitis C virus care cascade among people who inject drugs in puerto rico: Minimal HCV treatment and substantial barriers to HCV care
por: Aponte-Meléndez, Yesenia, et al.
Publicado: (2023)

2510. Adapting the CDC HCV viral clearance cascade methodology for persons with HIV (PWH) and HCV co-infection in 5 Health Department Jurisdictions in the US
por: Wegener, Maximilian D, et al.
Publicado: (2023)

Describing Engagement in the HIV Care Cascade: A Methodological Study
por: Jhuti, Diya, et al.
Publicado: (2023)

Challenges and barriers to HIV care engagement and care cascade: viewpoint
por: Bouabida, Khayreddine, et al.
Publicado: (2023)

Out-group animosity drives engagement on social media
por: Rathje, Steve, et al.
Publicado: (2021)

The Cascade of Care for Hepatitis C Treatment in Rwanda: A Retrospective Cohort Study of the 2017–2019 Mass Screening and Treatment Campaign
por: Nisingizwe, Marie Paul, et al.
Publicado: (2023)

Targeting HCV Entry For Development of Therapeutics
por: Wong-Staal, Flossie, et al.
Publicado: (2010)

957. Efficacy of Using Disease Intervention Specialists (DIS) to Re-engage Out of Care HIV/HCV Co-Infected Persons into HCV Treatment
por: Wegener, Maximilian D, et al.
Publicado: (2020)

Virtuous Meetings: Technology + Design for High Engagement in Large Groups
por: Danskin, Karl
Publicado: (2014)

Exploring the Effect of Collective Cultural Attributes on Covid-19-Related Public Health Outcomes
por: Erman, Aysegul, et al.
Publicado: (2021)

Community pharmacist engagement in HIV and HCV prevention: Current practices and potential for service uptake
por: Dowling-McClay, KariLynn, et al.
Publicado: (2021)

A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia
por: Butt, Zahid Ahmad, et al.
Publicado: (2017)

Key Elements on the Pathway to HCV Elimination: Lessons Learned From the AASLD HCV Special Interest Group 2020
por: Feld, Jordan J., et al.
Publicado: (2021)

Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study
por: Pearce, Margo E., et al.
Publicado: (2021)

Impact of HCV infection and ethnicity on incident type 2 diabetes: findings from a large population-based cohort in British Columbia
por: Jeong, Dahn, et al.
Publicado: (2021)

Comparative Risk of Myocarditis/Pericarditis Following Second Doses of BNT162b2 and mRNA-1273 Coronavirus Vaccines
por: Naveed, Zaeema, et al.
Publicado: (2022)

The impact of expanded access to direct acting antivirals for Hepatitis C virus on patient outcomes in Canada
por: Chu, Cherry, et al.
Publicado: (2023)

Elevated risk of colorectal, liver, and pancreatic cancers among HCV, HBV and/or HIV (co)infected individuals in a population based cohort in Canada
por: Darvishian, Maryam, et al.
Publicado: (2021)

Exploring NS3/4A, NS5A and NS5B proteins to design conserved subunit multi-epitope vaccine against HCV utilizing immunoinformatics approaches
por: Ikram, Aqsa, et al.
Publicado: (2018)

1062. HCV GET-UP: A Group Evaluation and Treatment Uptake Intervention Improves HCV Linkage to Care for PWID
por: Norton, Brianna L, et al.
Publicado: (2020)

Prevalence of HCV among the high risk groups in Khyber Pakhtunkhwa
por: Ali, Ijaz, et al.
Publicado: (2011)

Managing HCV Infection in Pediatric Age Group: Suggested Recommendations
por: Danish, Fazal A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_0e91tgbci77akqosbfb45ksipq